Novo Nordisk A/S

NONOF | OTC

Price Alert Chart Builder DCF Calculator

$40.02

-$2.60 (-6.09%)

At close: Sep 21, 2026, 3:49 PM ET

$39.92

-$0.10 (-0.25%)

After-hours: Sep 21, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020	FY 2019 Dec 30, 2019
Revenue	290.4B	232.26B	176.95B	140.8B	126.95B	122.02B
Cost of Revenue	44.52B	35.77B	28.45B	23.66B	20.93B	20.09B
Gross Profit	245.88B	196.5B	148.51B	117.14B	106.01B	101.93B
Operating Income	128.34B	102.57B	74.81B	58.64B	54.13B	52.48B
Interest Income	1.84B	1.07B	239M	231M	337M	65M
Pretax Income	127.19B	104.67B	69.06B	59.08B	53.13B	48.55B
Net Income	100.99B	83.68B	55.53B	47.76B	42.14B	38.95B
Selling & General & Admin	67.38B	61.6B	50.68B	41.06B	36.89B	35.83B
Research & Development	48.06B	32.44B	24.05B	17.77B	15.46B	14.22B
Other Expenses	2.1B	-119M	-1.03B	-332M	-460M	-600M
Operating Expenses	117.54B	93.92B	73.7B	58.5B	51.89B	49.45B
Interest Expense	1.64B	739M	378M	289M	390M	220M
Selling & Marketing Expenses	62.1B	56.74B	46.22B	37.01B	32.93B	31.82B
Cost & Expenses	162.06B	129.69B	102.15B	82.16B	72.82B	69.54B
Income Tax Expense	26.2B	20.99B	13.54B	11.32B	10.99B	9.6B
Shares Outstanding (Basic)	4.45B	4.49B	4.53B	4.59B	4.67B	4.75B
Shares Outstanding (Diluted)	4.46B	4.49B	4.54B	4.61B	4.68B	4.76B
EPS (Basic)	22.68	9.34	12.26	10.40	9.03	4.10
EPS (Diluted)	22.64	9.31	12.22	10.37	9.01	4.10
EBITDA	137.38B	109.81B	76.8B	64.83B	58.57B	56.31B
EBIT	128.83B	105.22B	69.81B	59.52B	54.13B	52.48B
Depreciation & Amortization	8.55B	5.83B	5.31B	5.31B	5.28B	4.68B